Ovarian cancer Trials in Amsterdam, Netherlands
Conditions / Ovarian cancer / Amsterdam, Netherlands
Clinical trials for Ovarian cancer investigate a range of treatment strategies and patient populations.
37 total trials for this combination
Showing top 10 of 37 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03149549 | PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors | TERMINATED | PHASE1/PHASE2 |
| NCT02418624 | Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer | COMPLETED | PHASE1 |
| NCT00433602 | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | COMPLETED | — |
| NCT02718417 | Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) | TERMINATED | PHASE3 |
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab | COMPLETED | PHASE1 |
| NCT02988817 | Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT07214779 | Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression | RECRUITING | — |
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00849667 | Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse | TERMINATED | PHASE3 |
| NCT05123482 | A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies | RECRUITING | PHASE1/PHASE2 |